NPLEx Brings A ‘Quiet’ Year On State PSE Legislation – CHPA
This article was originally published in The Tan Sheet
CHPA President and CEO Scott Melville says 2015 is the “quietest” in five years for state legislation on the sale of pseudoephedrine, a testament to NPLEx. Bills for Rx-only PSE sales introduced in four states this year failed.
Register for our free email digests: